Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 14, 2011

View Archived Issues

New carbapenem antibiotics described

Irosustat demonstrates pharmacodynamic proof of concept

New DNA vaccine is efficacious in monkey model of tuberculosis

Gantenerumab reduces amyloid levels in brain

Scientists in U.K. identify microRNA biomarker in COPD

Phase I/II data disclosed on trabedersen in melanoma, pancreatic and colorectal carcinoma

Intellikine advances first-in-human trial of INK-1117

Ironwood Pharmaceuticals prepares new GCS activators

Isis Pharmaceuticals selects second development candidate in GlaxoSmithKline collaboration

Dainippon Sumitomo Pharma discloses novel agents for sepsis

ISCO reports promising preclinical results with hpSC-derived neuronal cells

New deuterated dimethylcurcumin derivatives claimed by Concert Pharmaceuticals

Scientists at Gilead Sciences patent new SYK inhibitors

Novel histamine receptor antagonists presented by Kalypsys

Medicago completes first stage of noninfluenza VLP vaccine collaboration agreement

Michael J. Fox Foundation funds clinical study of Parkinson's disease vaccine

ISTA provides update on development of bromfenac ophthalmic solutions

Topline data reported from Pozen's phase III PA-32540 study

FDA grants pre-IND meeting to Advaxis for ADXS-HER2

DSMB recommends continuing Cyclacel's SEAMLESS trial

Micromet outlines registration strategy for blinatumomab

Kissei Pharmaceutical to pay MediciNova for further development of MN-221

Baxter International starts phase III trial of recombinant von Willebrand factor

FDA committee recommends approval of Zilver PTX paclitaxel-eluting stent

Telik commences phase IIb trial of Telintra

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...